Skip to main content
. 2012 Jan 24;14(3):149–157. doi: 10.1111/j.1751-7176.2011.00588.x

Figure 2.

Figure 2

 Change in blood pressure (BP) from baseline (week 0) to end of study by final dosing regimen. Baseline BP was defined as the mean of the randomization visit and the visit immediately preceding randomization; n is the number of study participants with values at both time points. AML indicates amlodipine besylate; HCTZ, hydrochlorothiazide; OM, olmesartan medoxomil; SD, standard deviation; SeBP, seated BP; SeDBP, seated diastolic BP; SeSBP, seated systolic BP.